Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B of A Securities analyst Tazeen Ahmad downgraded the rating for Sutro Biopharma, Inc. (NASDAQ:STRO) from Buy to Underperform and lowered the price target from $11 to $1. Sutro Biopharma shares closed at $1.25 on Thursday. See how other …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B of A Securities analyst Tazeen Ahmad downgraded the rating for Sutro Biopharma, Inc. (NASDAQ:STRO) from Buy to Underperform and lowered the price target from $11 to $1. Sutro Biopharma shares closed at $1.25 on Thursday. See how other …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
B of A Securities analyst Tazeen Ahmad downgraded the rating for Sutro Biopharma, Inc. (NASDAQ:STRO) from Buy to Underperform and lowered the price target from $11 to $1. Sutro Biopharma shares closed at $1.25 on Thursday. See how other …Full story available on Benzinga.com Read MoreAFCG, CMG, News, PTON, RVLV, STRO, TMUS, Top Downgrades, XPOF, Downgrades, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, CMG, US1696561059, TMUS, US8725901040, STRO, RVLV, PTON, AFCG, XPOF, News, Downgrades, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga News
